Peaks of Interest
Malvern Instruments Acquires Viscotek Corporation; Thermo Fisher Scientific Wins 2007 Frost and Sullivan Award; The Kinesis Group Acquires Abimed Analysen
Malvern Instruments Acquires Viscotek Corporation
Malvern Instruments (UK), a materials characterization company, announced its acquisition of Viscotek Corporation, a leading provider of chromatography solutions for the characterization of natural and synthetic polymers and proteins. Viscotek will bring new and complementary technologies and expertise to Malvern, adding gel permeation chromatography (GPC), flow injection polymer analysis (FIPA) and dilute solution viscosity (DSV), and extending the range of characterization solutions offered.
Viscotek Corporation, based in Houston, Texas, was founded in 1984 by Dr. Max Haney, inventor of the four-capillary differential viscometer detector. According to Paul Walker, Malvern's managing director, the alignment of Viscotek's products with Malvern's range will provide even more opportunity to comprehensively meet a broad range of customer needs. Viscotek's present management will continue to lead the business, which will operate as Viscotek Corporation, a Malvern Company.
Thermo Fisher Scientific Wins 2007 Frost & Sullivan Award
Thermo Fisher Scientific, Inc. (Waltham, Massachusetts) has been honored with the 2007 Frost & Sullivan Market Leadership Award for its outstanding contribution to the US High Content Screening (HCS) market. This award credits the company's expertise, insight into customer requirements, and technological innovation and advanced solutions for cell-based screening and analysis. Frost & Sullivan has identified Thermo Fisher as excellent in all areas of market leadership due to their ability to monitor market changes and implement strategies to meet the rapidly changing industry demands.
The Kinesis Group Acquires Abimed Analysen
The Kinesis group of companies (UK) announced its acquisition of Abimed Analysen, a German-based company focused on the chromatography and liquid handling markets.
According to the company, the acquisition of Abimed will provide the Kinesis group with an excellent platform to penetrate Europe's largest market.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
